EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

NSD Histone Methyltransferases in Solid Tumors: Biological Functions, Oncogenic Mechanisms and Therapeutic Targeting

Yan-Ting Yann Zhang iD, Andrew Plenn, Joey Sun, Cun Zhang, Phil Evans iD, Junsong Zhao, Huicong Li, Aurpita Shaha, Xiaodan Yao, Haiying Chen, Francis Spitz, Generosa Grana und 2 weitere

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27188115 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Yan-Ting Yann Zhang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Coriell Institute for Medical Research, 403 Haddon Ave, Camden, NJ 08103, USA. Hauptthemen laut MEDLINE: Neoplasms, Histone-Lysine N-Methyltransferase, Intracellular Signaling Peptides and Proteins, Histone Methyltransferases. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, United States Department of Defense, New Jersey Commission on Cancer Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epigenetic dysregulation is a defining feature of solid tumors. Among epigenetic regulators, the nuclear receptor-binding SET domain (NSD) family of histone methyltransferases, comprising NSD1, NSD2, and NSD3, have emerged as critical mediators of oncogenic chromatin remodeling and transcriptional regulation. These enzymes primarily catalyze histone H3 lysine 36 (H3K36) methylation, thereby regulating chromatin accessibility, transcriptional programs, DNA damage repair, and genome stability. Aberrant expression, mutation, amplification, and chromosomal rearrangement of NSD family members have been identified across tumors, establishing them as key epigenetic drivers of malignancy. Accumulating evidence demonstrates that NSD proteins promote multiple hallmarks of cancer, including sustained proliferative signaling, invasion and metastasis, immune evasion, metabolic reprogramming, genome instability, and therapeutic resistance. Although NSD proteins share overlapping catalytic functions, each exhibit distinct biological roles and mechanisms of dysregulation in solid tumors. Advances in structural biology, medicinal chemistry, and targeted protein degradation have accelerated the development of selective NSD inhibitors, chromatin-reader antagonists, and proteolysis-targeting chimeras (PROTACs), establishing the feasibility of pharmacologically targeting NSD-dependent epigenetic pathways. In this review, we summarize the biological functions of the NSD family, discuss their oncogenic mechanisms in solid tumors, and highlight recent progress in therapeutic targeting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHistone-Lysine N-MethyltransferaseIntracellular Signaling Peptides and ProteinsHistone MethyltransferasesHumansAnimalsEpigenesis, GeneticMolecular Targeted TherapyGene Expression Regulation, NeoplasticProteolysis Targeting ChimeraNuclear ProteinsHistonesRepressor Proteins

Stichwörter der Autor:innen

NSD1NSD2NSD3epigeneticshistone methylationsolid tumorstargeted therapy

Substanzen

Histone-Lysine N-MethyltransferaseNSD2 protein, humanNSD3 protein, humanNSD1 protein, humanIntracellular Signaling Peptides and ProteinsProteolysis Targeting ChimeraNuclear ProteinsHistone MethyltransferasesHistonesRepressor Proteins

Autor:innen und Institutionen

  • Coriell Institute for Medical Research, 403 Haddon Ave, Camden, NJ 08103, USA.
  • Department of Biomedical Sciences, Cooper Medical School of Rowan University, 401 Broadway, Camden, NJ 08103, USA.
  • Camden Cancer Research Center, 403 Haddon Ave, Camden, NJ 08103, USA.
  • Department of Pharmacology and Toxicology, University of Texas Medical Branch, Basic Science Building, 301 University Boulevard, Galveston, TX 77555, USA.
  • MD Anderson Cancer Center at Cooper, Cooper University Hospital, 2 Cooper Plaza, Camden, NJ 08103, USA.
  • Cooper University Hospital, Department of Surgery, Cooper Medical School of Rowan University, 1 Cooper Plaza, Camden, NJ 08103, USA.

ORCID-Profile: Yan-Ting Yann Zhang, Phil Evans, Jia Zhou, Shumei Song

Förderung

  • NCI NIH HHS
  • United States Department of Defense
  • New Jersey Commission on Cancer Research
  • NIH
  • DOD
  • NJCCR

Zitieren

APA

Zhang, Y. Y., Plenn, A., Sun, J., Zhang, C., Evans, P., Zhao, J., Li, H., Shaha, A., Yao, X., Chen, H., Spitz, F., Grana, G., Zhou, J., & Song, S. (2026). NSD Histone Methyltransferases in Solid Tumors: Biological Functions, Oncogenic Mechanisms and Therapeutic Targeting. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27188115

Vancouver

Zhang YY, Plenn A, Sun J, Zhang C, Evans P, Zhao J, et al. NSD Histone Methyltransferases in Solid Tumors: Biological Functions, Oncogenic Mechanisms and Therapeutic Targeting. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27188115

BibTeX
@article{Zhang2026,
  author = {Zhang, Yan-Ting Yann and Plenn, Andrew and Sun, Joey and Zhang, Cun and Evans, Phil and Zhao, Junsong and Li, Huicong and Shaha, Aurpita and Yao, Xiaodan and Chen, Haiying and Spitz, Francis and Grana, Generosa and Zhou, Jia and Song, Shumei},
  title = {NSD Histone Methyltransferases in Solid Tumors: Biological Functions, Oncogenic Mechanisms and Therapeutic Targeting},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27188115}
}
Kostenlos starten →